|
1
|
Rendon A and Schäkel K: Psoriasis
pathogenesis and treatment. Int J Mol Sci. 20(1475)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kamiya K, Kishimoto M, Sugai J, Komine M
and Ohtsuki M: Risk factors for the development of psoriasis. Int J
Mol Sci. 20(4347)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tokuyama M and Mabuchi T: New treatment
addressing the pathogenesis of psoriasis. Int J Mol Sci.
21(7488)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tashiro T and Sawada Y: Psoriasis and
systemic inflammatory disorders. Int J Mol Sci.
23(4457)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hao Y, Zhu YJ, Zou S, Zhou P, Hu YW, Zhao
QX, Gu LN, Zhang HZ, Wang Z and Li J: Metabolic syndrome and
psoriasis: Mechanisms and future directions. Front Immunol.
12(711060)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lowes MA, Russell CB, Martin DA, Towne JE
and Krueger JG: The IL-23/T17 pathogenic axis in psoriasis is
amplified by keratinocyte responses. Trends Immunol. 34:174–181.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hawkes JE, Yan BY, Chan TC and Krueger JG:
Discovery of the IL-23/IL-17 signaling pathway and the treatment of
psoriasis. J Immunol. 201:1605–1613. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Griffiths CEM, Armstrong AW, Gudjonsson JE
and Barker JNWN: Psoriasis. Lancet. 397:1301–1315. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kamata M and Tada Y: Crosstalk:
Keratinocytes and immune cells in psoriasis. Front Immunol.
14(1286344)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Montero-Vilchez T,
Segura-Fernández-Nogueras MV, Pérez-Rodríguez I, Soler-Gongora M,
Martinez-Lopez A, Fernández-González A, Molina-Leyva A and
Arias-Santiago S: Skin barrier function in psoriasis and atopic
dermatitis: Transepidermal water loss and temperature as useful
tools to assess disease severity. J Clin Med.
10(359)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Korman NJ: Management of psoriasis as a
systemic disease: What is the evidence? Br J Dermatol. 182:840–848.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Malter JS: Pin1 and Alzheimer's disease.
Transl Res. 254:24–33. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Caligiuri I, Vincenzo C, Asano T, Kumar V
and Rizzolio F: The metabolic crosstalk between PIN1 and the tumour
microenvironment. Semin Cancer Biol. 91:143–157. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li J, Mo C, Guo Y, Zhang B, Feng X, Si Q,
Wu X, Zhao Z, Gong L, He D and Shao J: Roles of peptidyl-prolyl
isomerase Pin1 in disease pathogenesis. Theranostics. 11:3348–3358.
2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cheng CW and Tse E: PIN1 in cell cycle
control and cancer. Front Pharmacol. 9(1367)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nishi M, Akutsu H, Masui S, Kondo A,
Nagashima Y, Kimura H, Perrem K, Shigeri Y, Toyoda M, Okayama A, et
al: A distinct role for Pin1 in the induction and maintenance of
pluripotency. J Biol Chem. 286:11593–11603. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nakamura K, Kosugi I, Lee DY, Hafner A,
Sinclair DA, Ryo A and Lu KP: Prolyl isomerase Pin1 regulates
neuronal differentiation via β-catenin. Mol Cell Biol.
32:2966–2978. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lee YM, Shin SY, Jue SS, Kwon IK, Cho EH,
Cho ES, Park SH and Kim EC: The role of PIN1 on odontogenic and
adipogenic differentiation in human dental pulp stem cells. Stem
Cells Dev. 23:618–630. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Luo ML, Gong C, Chen CH, Lee DY, Hu H,
Huang P, Yao Y, Guo W, Reinhardt F, Wulf G, et al: Prolyl isomerase
Pin1 acts downstream of miR200c to promote cancer stem-like cell
traits in breast cancer. Cancer Res. 74:3603–3616. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rustighi A, Zannini A, Tiberi L, Sommaggio
R, Piazza S, Sorrentino G, Nuzzo S, Tuscano A, Eterno V, Benvenuti
F, et al: Prolyl-isomerase Pin1 controls normal and cancer stem
cells of the breast. EMBO Mol Med. 6:99–119. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kanamoto M, Takahagi S, Aoyama S, Kido Y,
Nakanishi M, Naito M, Kanna M, Yamamotoya T, Tanaka A, Hide M, et
al: The expression of prolyl isomerase Pin1 is expanded in the skin
of patients with atopic dermatitis and facilitates IL-33 expression
in HaCaT cells. J Dermatol. 50:462–471. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xu F, Armstrong R, Urrego D, Qazzaz M,
Pehar M, Armstrong JN, Shutt T and Syed N: The mitochondrial
division inhibitor Mdivi-1 rescues mammalian neurons from
anesthetic-induced cytotoxicity. Mol Brain. 9(35)2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
So EC, Hsing CH, Liang CH and Wu SN: The
actions of mdivi-1, an inhibitor of mitochondrial fission, on
rapidly activating delayed-rectifier K+ current and
membrane potential in HL-1 murine atrial cardiomyocytes. Eur J
Pharmacol. 683:1–9. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Raharja A, Mahil SK and Barker JN:
Psoriasis: A brief overview. Clin Med (Lond). 21:170–173.
2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhou X, Chen Y, Cui L, Shi Y and Guo C:
Advances in the pathogenesis of psoriasis: From keratinocyte
perspective. Cell Death Dis. 13(81)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen HL, Lo CH, Huang CC, Lu MP, Hu PY,
Chen CS, Chueh DY, Chen P, Lin TN, Lo YH, et al: Galectin-7
downregulation in lesional keratinocytes contributes to enhanced
IL-17A signaling and skin pathology in psoriasis. J Clin Invest.
131(e130740)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yu JH, Im CY and Min SH: Function of PIN1
in cancer development and its inhibitors as cancer therapeutics.
Front Cell Dev Biol. 8(120)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim G, Bhattarai PY, Lim SC, Kim JY and
Choi HS: PIN1 facilitates ubiquitin-mediated degradation of
serine/threonine kinase 3 and promotes melanoma development via TAZ
activation. Cancer Lett. 499:164–174. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jeong HG, Pokharel YR, Lim SC, Hwang YP,
Han EH, Yoon JH, Ahn SG, Lee KY and Kang KW: Novel role of Pin1
induction in type II collagen-mediated rheumatoid arthritis. J
Immunol. 183:6689–6697. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ge ZZ, Wu YB, Xue ZY, Zhang K and Zhang
RX: The therapeutic effects of the peptidyl-prolyl cis/trans
isomerase Pin1 inhibitor juglone on animal-model experimental
autoimmune encephalomyelitis. J Physiol Pharmacol: Aug 6, 2021
(Epub ahead of print).
|
|
32
|
Wahedi HM, Park YU, Moon EY and Kim SY:
Juglone ameliorates skin wound healing by promoting skin cell
migration through Rac1/Cdc42/PAK pathway. Wound Repair Regen.
24:786–794. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Quyen BT, Choi HK and Kang KW: Pin1 is
required for ultraviolet A-stimulated cyclooxygenase-2 induction in
mouse epidermal cells. Cancer Lett. 335:31–40. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Han YC, Liu YT, Zhang H, Xu Y, Liu J, Chen
H, Song N, Qin DL and Yang S: VDR alleviates endothelial cell
injury in arteriovenous fistula through inhibition of
P66Shc-mediated mitochondrial ROS. Sci Rep.
13(11088)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Feng D, Yao J, Wang G, Li Z, Zu G, Li Y,
Luo F, Ning S, Qasim W, Chen Z and Tian X: Inhibition of
p66Shc-mediated mitochondrial apoptosis via targeting
prolyl-isomerase Pin1 attenuates intestinal ischemia/reperfusion
injury in rats. Clin Sci (Lond). 131:759–773. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lemasters JJ: Selective mitochondrial
autophagy, or mitophagy, as a targeted defense against oxidative
stress, mitochondrial dysfunction, and aging. Rejuvenation Res.
8:3–5. 2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lv Z, Zhang Y, Cao H, Liu Q, Feng X, Yin H
and Wang B: PIN1 protects auditory hair cells from senescence via
autophagy. PeerJ. 10(e14267)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Gholamzadeh Khoei S, Saidijam M, Amini R,
Jalali A and Najafi R: Impact of PIN1 inhibition on tumor
progression and chemotherapy sensitivity in colorectal cancer. J
Gastrointest Cancer. 53:299–310. 2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yanli M, Yu W and Yuzhen L: Elevated SIRT3
Parkin-dependently activates cell mitophagy to ameliorate
TNF-α-induced psoriasis-related phenotypes in HaCaT cells through
deacetylating FOXO3a for its activation. Arch Dermatol Res.
315:847–857. 2023.PubMed/NCBI View Article : Google Scholar
|
